Sol-Gel Technologies (SLGL) Competitors $40.32 -0.19 (-0.47%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$40.32 0.00 (0.00%) As of 08:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLGL vs. CHEK, DRCT, NGNE, ENGN, FDMT, DBVT, KRRO, EOLS, BNTC, and YMABShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Check-Cap (CHEK), Direct Digital (DRCT), Neurogene (NGNE), enGene (ENGN), 4D Molecular Therapeutics (FDMT), DBV Technologies (DBVT), Korro Bio (KRRO), Evolus (EOLS), Benitec Biopharma (BNTC), and Y-mAbs Therapeutics (YMAB). Sol-Gel Technologies vs. Its Competitors Check-Cap Direct Digital Neurogene enGene 4D Molecular Therapeutics DBV Technologies Korro Bio Evolus Benitec Biopharma Y-mAbs Therapeutics Sol-Gel Technologies (NASDAQ:SLGL) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Does the media prefer SLGL or CHEK? In the previous week, Check-Cap had 1 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for Sol-Gel Technologies. Check-Cap's average media sentiment score of 1.00 beat Sol-Gel Technologies' score of 0.00 indicating that Check-Cap is being referred to more favorably in the news media. Company Overall Sentiment Sol-Gel Technologies Neutral Check-Cap Positive Which has more risk & volatility, SLGL or CHEK? Sol-Gel Technologies has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Do insiders and institutionals believe in SLGL or CHEK? 26.2% of Sol-Gel Technologies shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 66.5% of Sol-Gel Technologies shares are held by insiders. Comparatively, 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher valuation & earnings, SLGL or CHEK? Sol-Gel Technologies has higher revenue and earnings than Check-Cap. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$11.54M9.75-$10.58M-$1.23-32.78Check-CapN/AN/A-$25.15M-$3.00-0.61 Is SLGL or CHEK more profitable? Check-Cap has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -14.25%. Check-Cap's return on equity of 0.00% beat Sol-Gel Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-14.25% -11.80% -9.39% Check-Cap N/A N/A N/A Do analysts prefer SLGL or CHEK? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sol-Gel Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummarySol-Gel Technologies beats Check-Cap on 7 of the 13 factors compared between the two stocks. Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$112.49M$4.44B$6.13B$10.55BDividend YieldN/A0.88%5.72%4.83%P/E Ratio-32.7810.8529.3427.06Price / Sales9.7521.85595.40132.25Price / CashN/A7.4625.8230.35Price / Book3.894.2712.236.58Net Income-$10.58M-$134.23M$3.33B$276.84M7 Day Performance0.93%0.32%0.61%-0.72%1 Month Performance32.20%12.18%6.81%2.16%1 Year Performance482.24%64.25%58.96%34.63% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies0.6527 of 5 stars$40.32-0.5%N/A+482.2%$112.49M$11.54M-32.7850Gap DownCHEKCheck-Cap0.5614 of 5 stars$1.91+3.8%N/A+27.3%$10.77MN/A-0.6480Positive NewsShort Interest ↓Gap DownDRCTDirect Digital2.3722 of 5 stars$0.35+4.6%$6.00+1,624.1%-88.8%$7.49M$62.29M-0.1960Short Interest ↑NGNENeurogene1.5467 of 5 stars$31.62+4.7%$46.17+46.0%-46.6%$431.15M$930K-7.3490ENGNenGene3.0998 of 5 stars$8.29-1.2%$19.50+135.2%+3.7%$429.50MN/A-4.3631FDMT4D Molecular Therapeutics3.1727 of 5 stars$9.67+8.7%$30.40+214.4%+15.4%$415.65M$40K-2.74120Analyst RevisionHigh Trading VolumeDBVTDBV Technologies1.2361 of 5 stars$16.42+9.5%$14.75-10.2%+380.8%$410.93M$4.15M-3.4480Positive NewsGap UpHigh Trading VolumeKRROKorro Bio2.0844 of 5 stars$45.71+6.4%$86.83+90.0%-47.3%$403.53M$2.27M-4.6970EOLSEvolus3.9305 of 5 stars$6.00-2.3%$21.25+254.2%-61.5%$397.17M$266.27M-6.12170BNTCBenitec Biopharma1.2266 of 5 stars$15.00+0.5%$24.80+65.3%+36.3%$391.66M$80K-10.2020YMABY-mAbs Therapeutics1.332 of 5 stars$8.61flat$9.62+11.8%N/A$391.24M$87.68M-17.22150 Related Companies and Tools Related Companies Check-Cap Alternatives Direct Digital Alternatives Neurogene Alternatives enGene Alternatives 4D Molecular Therapeutics Alternatives DBV Technologies Alternatives Korro Bio Alternatives Evolus Alternatives Benitec Biopharma Alternatives Y-mAbs Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLGL) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
